type here...

Latest news

Insights

How Is AI Transforming Drug Discovery in 2026?

Executive Summary In 2026, AI drug discovery has moved beyond pilot projects and strategic partnerships to become embedded infrastructure within...
Commercial

Candel Secures $100 Million From RTW Ahead of Planned FDA Filing for Prostate Cancer Therapy

Candel Therapeutics has obtained a $100 million financing commitment from RTW Investments as it prepares to seek U.S. regulatory...
Clinical

Grail’s NHS-Galleri Trial Misses Primary Endpoint

In top-line results released alongside full-year financial figures, Grail said the NHS-Galleri study failed to demonstrate a statistically significant...
Regulatory

Critical vaccine panel will not meet in February due to CDC turmoil

CDC turmoil,Since the recent modifications of the U.S. vaccine policy have been met with criticism on multiple levels, one...
Regulatory

Novartis to Seek Full FDA Approval for Vanrafia in IgA Nephropathy After Phase 3 ALIGN Miss

Novartis announced that it will pursue traditional approval from...
Regulatory

FDA Rejects Disc Medicine’s Bitopertin for EPP After Priority Voucher Review

The U.S. Food and Drug Administration has declined to...
Clinical

Approval push by BridgeBio after dwarfism drug boosts the height of children in phase 3

BridgeBio is optimistic that infigratinib will have a second opportunity to receive approval following the drug achieving its target...
Clinical

Kailera, Hengrui Move Ahead With Obesity Pill Following Positive Mid-Stage Data

The Massachusetts-based biotech company Kailera and its Chinese partner, Hengrui, have reported top-line findings from a phase 2 trial...
Commercial

Madrigal Expands MASH Pipeline with $60 Million Ribo siRNA Deal

Madrigal Pharmaceuticals has entered into a preclinical collaboration with Suzhou Ribo Life Science and its subsidiary Ribocure Pharmaceuticals to...
Regulatory

FDA’s refusal to file a letter for mRNA flu vaccination hits Moderna, and the agency’s justification faces criticism

Indications of an anti-mRNA bias in the FDA and...
Clinical

Evommune Reports Phase 2a EVO301 Data in Moderate to Severe Atopic Dermatitis

Evommune disclosed results from a phase 2a clinical trial...
Regulatory

FDA Rejects REGENXBIO’s RGX-121 Gene Therapy for Hunter Syndrome, Requests New Study

The U.S. Food and Drug Administration (FDA) has issued a complete response letter rejecting REGENXBIO’s application for accelerated approval...
Clinical

Eli Lilly Discontinues Three Clinical-Stage Programs Including Prevail Gene Therapy

Eli Lilly has discontinued three clinical-stage drug candidates as it awaits an FDA approval decision for its oral GLP-1...
Regulatory

Pfizer EU Tafamidis Patent Withdrawal

Pfizer withdrew European patent EP3191461B1 during a hearing with the European Patent Office. The patent covered certain crystalline solid...
Regulatory

Critical vaccine panel will not meet in February due to CDC turmoil

CDC turmoil,Since the recent modifications of the U.S. vaccine...
Editorial Team -
Commercial

Candel Secures $100 Million From RTW Ahead of Planned FDA Filing for Prostate Cancer Therapy

Candel Therapeutics has obtained a $100 million financing commitment...
Editorial Team -
Commercial

$370M bid by Olympus for the acquisition of Taewoong Medical

Olympus has made a $370M bid to acquire Taewoong...
Commercial

Cerveau and its Alzheimer’s imaging technology acquired by Lantheus

Lantheus is expanding its line of radiopharmaceuticals by acquiring...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team -

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers...
Editorial Team -

Regulatory

Regulatory

Critical vaccine panel will not meet in February due to CDC turmoil

CDC turmoil,Since the recent modifications of the U.S. vaccine...
Editorial Team -
Commercial

Candel Secures $100 Million From RTW Ahead of Planned FDA Filing for Prostate Cancer Therapy

Candel Therapeutics has obtained a $100 million financing commitment...
Clinical

Grail’s NHS-Galleri Trial Misses Primary Endpoint

In top-line results released alongside full-year financial figures, Grail...
Regulatory

Critical vaccine panel will not meet in February due to CDC turmoil

CDC turmoil,Since the recent modifications of the U.S. vaccine...
Regulatory

Merck Looking For FDA Green Light For Englonsia Beyond First RSV Season

As Enflonsia nears the first anniversary of its FDA...

Research & Development

Market Access

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

How Is AI Transforming Drug Discovery in 2026?

Executive Summary In 2026, AI drug discovery has moved beyond...
Editorial Team -
Manufacturing

Recipharm Commissions Bengaluru Facility for Nonbacterial Beta-Lactam Tablet Manufacturing

Swedish contract development and manufacturing organization (CDMO) Recipharm has...
Editorial Team -
Clinical

Grail’s NHS-Galleri Trial Misses Primary Endpoint

In top-line results released alongside full-year financial figures, Grail...
Editorial Team -

Editor Picks

Must Read

Hot Topics

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Contact us: reachout(at)lifescivoice.com

Follow Us

© Copyright - Life Sciences Voice